PainTEQ's LinQ therapy aims to immediately provide clinical benefits to individuals living with incapacitating lower back pain through a minimally invasive outpatient procedure.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/10/23 | $35,000,000 | Debt Financing |
MVolution Partners | undisclosed |
| 08/27/25 | undisclosed | Majority Growth |
MVolution Partners Signet Healthcare Partners Windham Capital Partners | undisclosed |
